Treatment of a mutant KRAS lung cancer cell line with polyisoprenylated cysteinyl amide inhibitors activates the MAPK pathway, inhibits cell migration and induces apoptosis
Matthew D. Gregory(Florida Agricultural and Mechanical University), Nazarius S. Lamango(Florida Agricultural and Mechanical University)
Cited by 5
Related Papers
Polyisoprenylated cysteinyl amide inhibitors disrupt actin cytoskeleton organization, induce cell rounding and block migration of non-small cell lung cancer
|Oncotarget|2017|21